Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells

BIOLOGICAL3 trials

Sponsors

Medipost Co Ltd., Medipost, Inc.

Conditions

Bronchopulmonary DysplasiaDementia of the Alzheimer's Type

Phase 1

Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia

CompletedNCT01297205

Medipost Co Ltd.Bronchopulmonary Dysplasia

Start: 2010-12-31End: 2011-12-31Updated: 2014-04-07

The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease

CompletedNCT01297218

Medipost Co Ltd.Dementia of the Alzheimer's Type

Start: 2011-02-28End: 2011-12-31Updated: 2012-04-23

Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study

CompletedNCT02381366

Medipost, Inc.Bronchopulmonary Dysplasia

Start: 2015-03-31End: 2018-05-31Updated: 2018-08-16

Related Papers

Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial)

Trials2020-01-3126 citations

Safety of Intratracheal Administration of Human Umbilical Cord Blood Derived Mesenchymal Stromal Cells in Extremely Low Birth Weight Preterm Infants.

2019-04-1385 citations

Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial

Alzheimer s & Dementia Translational Research & Clinical Interventions2015-07-23208 citations